A Randomized, Double-blind, Controlled, Parallel-group, Single Dose, Three arm Study to Compare the Pharmacokinetic Similarity of MAB-22 Versus Prolia® Sourced from the European Union and United States in Healthy Male Participants

Status

Completed

Phases

Phase 1

Study type

Interventional

Source

EU CTIS

Registry ID

CTIS2023-509749-11-00

Acronym

MAB-22-101

Enrollment

225

Registered

2024-05-30

Start date

2024-06-05

Completion date

2025-07-17

Last updated

2025-08-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Healthy volunteers

None listed

Sex/Gender

Male

Age

18 Years to 64 Years

Hungary, Netherlands

None listed

Source: EU CTIS · Data processed: Feb 4, 2026